A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL

Published:2022-02 Issue:2 Volume:30 Page:550-563
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Zanetti Samanta Romina,Velasco-Hernandez Talia,Gutierrez-Agüera Francisco,Díaz Víctor M.,Romecín Paola Alejandra,Roca-Ho Heleia,Sánchez-Martínez Diego,Tirado Néstor,Baroni Matteo Libero,Petazzi Paolo,Torres-Ruiz Raúl,Molina Oscar,Bataller Alex^ORCID,Fuster José Luis^ORCID,Ballerini Paola,Juan Manel,Jeremias Irmela^ORCID,Bueno Clara,Menéndez Pablo

Funder

Ministerio de Economía y Competitividad

Fundacion La Caixa

European Research Council

Carlos III Health Institute

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference39 articles.

1. Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden;Katz;Cancer Causes Control,2015

2. Novel Therapies in the Treatment of Adult Acute Lymphoblastic Leukemia;Gavralidis;Curr. Hematol. Malig. Rep.,2020

3. CAR-T immunotherapy: how will it change treatment for acute lymphoblastic leukemia and beyond?;Capitini;Expert Opin. Orphan Drugs,2018

4. A guide to cancer immunotherapy: from T cell basic science to clinical practice;Waldman;Nat. Rev. Immunol.,2020

5. CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy;Scheuermann;Leuk. Lymphoma,1995

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia;2024-09-03

2. Generation of non-genetically modified, CAR-like, NK cells;Journal for ImmunoTherapy of Cancer;2024-07

3. A novel loop-structure-based bispecific CAR that targets CD19 and CD22 with enhanced therapeutic efficacy against B-cell malignances;Protein & Cell;2024-06-01

4. Novel and multiple targets for chimeric antigen receptor-based therapies in lymphoma;Frontiers in Oncology;2024-04-22

5. The role of chimeric antigen receptor T cells targeting more than one antigen in the treatment of B‐cell malignancies;British Journal of Haematology;2024-02-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3